Related references
Note: Only part of the references are listed.Novel fusion peptide-mediated siRNA delivery using self-assembled nanocomplex
Yeong Chae Ryu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer
Ming Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Intercalated kaolinite as an emerging platform for cancer therapy
Yi Zhang et al.
SCIENCE CHINA-CHEMISTRY (2019)
RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway
Jian-Ye Liu et al.
BRITISH JOURNAL OF CANCER (2018)
SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival
J. Y. Liu et al.
ONCOGENE (2018)
MicroRNA-1179 suppresses cell growth and invasion by targeting sperm-associated antigen 5-mediated Akt signaling in human non-small cell lung cancer
Lingqin Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation
Hongliang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
Yu-Feng Yang et al.
MOLECULAR CANCER (2018)
An ultra-stable redox-controlled self-assembling polypeptide nanotube for targeted imaging and therapy in cancer
Gitanjali Asampille et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Preventive effect of intravesical ozone supplementation on n-methyl-n-nitrosourea-induced non-muscle invasive bladder cancer in male rats
Kerem Teke et al.
EXPERIMENTAL ANIMALS (2017)
Intercalated 2D nanoclay for emerging drug delivery in cancer therapy
Yi Zhang et al.
NANO RESEARCH (2017)
miR-539 inhibits prostate cancer progression by directly targeting SPAG5
Hongtuan Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis
Tarek M. A. Abdel-Fatah et al.
LANCET ONCOLOGY (2016)
Comparative proteomic analyses of urine from rat urothelial carcinoma chemically induced by exposure to N-butyl-N-(4-hydroxybutyl)-nitrosamine
Rita Ferreira et al.
MOLECULAR BIOSYSTEMS (2015)
Nanotubes With Well-Defined Structure: Single- and Double-Walled Imogolites
Maicon P. Lourenco et al.
JOURNAL OF PHYSICAL CHEMISTRY C (2014)
Probing Anisotropic Surface Properties and Interaction Forces of Chrysotile Rods by Atomic Force Microscopy and Rheology
Dingzheng Yang et al.
LANGMUIR (2014)
SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway
L-J Yuan et al.
CELL DEATH & DISEASE (2014)
Clay: New Opportunities for Tissue Regeneration and Biomaterial Design
Jonathan I. Dawson et al.
ADVANCED MATERIALS (2013)
Cause-specific mortality in a Chinese chrysotile textile worker cohort
Xiaorong Wang et al.
CANCER SCIENCE (2013)
Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells
Kathrin Thedieck et al.
CELL (2013)
A Targeted RNAi Screen of the Breast Cancer Genome Identifies KIF14 and TLN1 as Genes That Modulate Docetaxel Chemosensitivity in Triple-Negative Breast Cancer
Stina Mui Singel et al.
CLINICAL CANCER RESEARCH (2013)
The Tumor Microenvironment Contribution to Development, Growth, Invasion and Metastasis of Head and Neck Squamous Cell Carcinomas
Sittichai Koontongkaew
JOURNAL OF CANCER (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
Joshua A. Bauer et al.
BREAST CANCER RESEARCH (2010)
Small RNAs in transcriptional gene silencing and genome defence
Danesh Moazed
NATURE (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
siRNA and Innate Immunity
Marjorie Robbins et al.
OLIGONUCLEOTIDES (2009)
Effects of the Kava Chalcone Flavokawain A Differ in Bladder Cancer Cells with Wild-type versus Mutant p53
Yaxiong Tang et al.
CANCER PREVENTION RESEARCH (2008)
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes
David B. Rozema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration
Jiangxue Wang et al.
TOXICOLOGY LETTERS (2007)
Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells
Hee Jun Cho et al.
CANCER LETTERS (2006)
Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo
XY Niu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
AD Judge et al.
NATURE BIOTECHNOLOGY (2005)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
